Status:
COMPLETED
Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Bristol-Myers Squibb
Conditions:
Caregiver
Malignant Neoplasm
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This phase I/II trial studies how well patient portal and navigation program work in providing information for Asian American cancer patients. Patient portal and navigation program may help to improve...
Detailed Description
PRIMARY OBJECTIVES: I. Identify Asian American adults newly diagnosed with colorectal, liver, or lung cancer using a population-based cancer registry. II. Conduct outreach to these patients to let t...
Eligibility Criteria
Inclusion
- FOR INTERVIEWS AND FOCUS GROUPS:
- Cancer patients: Self-identifies as Asian American, lives in San Francisco, speaks English, Mandarin, Cantonese, or Vietnamese, has a history of cancer of any kind
- Caregivers: any person age 21 and older who has provided care to an Asian American cancer patient
- Health professionals: physicians and other health professionals age 21 and older who provide care to Asian American patients with cancer
- FOR PILOT IMPLEMENTATION:
- Self-identifies as Asian American
- Ages 21 or older
- Lives in the 9 counties of the greater bay area cancer registry (GBACR)
- Speaks English, Mandarin, Cantonese, or Vietnamese
- Has any stage colorectal, lung, or liver cancer
- Has not started treatment or has not completed treatment
- Is willing to stay in the study for six months.
- FOR FULL IMPLEMENTATION:
- Self-identifies as Asian American
- Ages 21 or older
- Lives in the 9 counties of the GBACR
- Speaks English, Mandarin, Cantonese, or Vietnamese
- Has any stage colorectal, lung, or liver cancer,
- Has not started or has not completed treatment
- Is willing to stay in the study for six-seven months
Exclusion
- \*Any medical or psychological conditions precluding informed consent
Key Trial Info
Start Date :
December 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT03867916
Start Date
December 13 2018
End Date
December 31 2022
Last Update
January 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94158